PTCT — PTC Therapeutics Inc · rev $633.1M

PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.

Latest reported PTCT revenue for 2026-06-30 was $633.1M. Net income was $80.7M. PTCT currently screens at market cap $6.51B.

Use this PTCT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PTCT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PTCT SEC filings page. Lician reads the product cache first so this HTML stays unique to PTC Therapeutics Inc even when a live quote feed is slow.

PTC Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full PTCT income, balance, and cash tables.

  • Revenue$1.73B
  • Net Income$682.6M
  • Total Assets$2.90B
  • Total Debt$0
  • Free Cash Flow$702.3M

PTCT recent filings